Head-to-head · Cost-Efficiency Index
PlexusDx vs No BS RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
PlexusDx
Shoppers who want a published starting price with an oral semaglutide option, all 50 states.
Visit PlexusDxNo BS RX
Someone who wants every term and every dose level comparable without starting an intake to see a price.
Visit No BS RXThe verdict
PlexusDx and No BS RX tie on the Cost-Efficiency Index at 82/100, so neither wins outright on the numbers. For most shoppers we'd start with PlexusDx (ranked #27, a hair above #28) — Shoppers who want a published starting price with an oral semaglutide option, all 50 states. But No BS RX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs PlexusDx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | PlexusDx | No BS RX |
|---|---|---|
| Cost-Efficiency Index | 82/100 | 82/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | $179/mo month-to-month; a separate low-dose program runs $140 |
| Tirzepatide / mo | $249/mo (all doses, compounded) | $249/mo month-to-month; a separate low-dose program runs $140 |
| Semaglutide / yr (modeled) | $1,788 | $2,148 |
| Tirzepatide / yr (modeled) | $2,988 | $2,988 |
| Coverage | All 50 states | Not disclosed |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #27 | #28 |
PlexusDx
82/100Where the value is
- LegitScript Certified, stated directly on the homepage
- Both injection and oral tablet formats for semaglutide from the same starting price
- All 50 states served
The tradeoffs
- 'Starts at' pricing — the page does not disclose what higher doses cost, so $149/$249 is a floor, not what most patients settling into a maintenance dose will pay
- No named prescriber, medical director, or specific compounding pharmacy
No BS RX
82/100Where the value is
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
The tradeoffs
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.